Back
Karuna Therapeutics Vs. Gossamer Bio Industry Stock Comparison
Sell
30
KRTX
Karuna Therapeutics
Last Price:
169.57
Seasonality Move:
21.88%
Sell
12
GOSS
Gossamer Bio
Last Price:
1.11
Seasonality Move:
1.2%
Sell
30
Karuna Therapeutics (KRTX)
is a Sell
Is Karuna Therapeutics a Buy, Sell or Hold?
- The current Karuna Therapeutics [KRTX] share price is $161.33. The Score for KRTX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- KRTX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
12
Gossamer Bio (GOSS)
is a Sell
Is Gossamer Bio a Buy, Sell or Hold?
- The current Gossamer Bio [GOSS] share price is $1.19. The Score for GOSS is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
- GOSS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
KRTX Stock Price Chart
What is Karuna Therapeutics's stock price today?
-
The Karuna Therapeutics share price today is $161.33
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KRTX is experiencing selling pressure, which indicates risk of future bearish movement.
GOSS Stock Price Chart
What is Gossamer Bio's stock price today?
-
The Gossamer Bio share price today is $1.19
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GOSS is experiencing slight buying pressure.
KRTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.29 | Sell |
| Relative Strength Index (14 RSI): | 27.82 | Sell |
| Chaikin Money Flow: | -1277945 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (182.8 - 198.4) | Sell |
| Bollinger Bands (100): | (187.9 - 218.52) | Sell |
GOSS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.29 | Sell |
| Relative Strength Index (14 RSI): | 33.72 | Sell |
| Chaikin Money Flow: | 591958 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.27 - 2.01) | Sell |
| Bollinger Bands (100): | (0.7 - 7.72) | Sell |
KRTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 183 | Sell |
| 20-day SMA: | 189.93 | Sell |
| 50-day SMA: | 192.7 | Sell |
| 200-day SMA: | 194.86 | Sell |
| 8-day EMA: | 181.87 | Sell |
| 20-day EMA: | 187.41 | Sell |
| 50-day EMA: | 192.96 | Sell |
| 200-day EMA: | 188.12 | Sell |
GOSS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.23 | Sell |
| 20-day SMA: | 1.5 | Sell |
| 50-day SMA: | 2.01 | Sell |
| 200-day SMA: | 7.78 | Sell |
| 8-day EMA: | 1.24 | Sell |
| 20-day EMA: | 1.5 | Sell |
| 50-day EMA: | 2.29 | Sell |
| 200-day EMA: | 6.2 | Sell |
Karuna Therapeutics Earnings Growth & KRTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.08 per share, and an increase next year of $1.47 per share.
Gossamer Bio Earnings Growth & GOSS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.13 per share, an increase this year of $0.66 per share, and an increase next year of $0.21 per share.
Karuna Therapeutics Technical Analysis
| Mar-8 | Mar-9 | Mar-10 | Mar-13 | Mar-14 | Mar-15 | Mar-16 | Mar-17 | Mar-20 | Mar-21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Gossamer Bio Technical Analysis
| Mar-8 | Mar-9 | Mar-10 | Mar-13 | Mar-14 | Mar-15 | Mar-16 | Mar-17 | Mar-20 | Mar-21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||